Evidence map›Paper›PMID 34183802›Full record

ArticleNature biomedical engineering2021

An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma.

Jongmin Park, Jun Seok Park, Chen-Han Huang, Ala Jo, Kaitlyn Cook, Rui Wang, Hsing-Ying Lin, Jan Van Deun, Huiyan Li, Jouha Min and 8 more

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 195 citations in OpenAlex.

  1. Prognostic value of extracellular vesicles in colorectal cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. A Nanoparticle-Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Extracellular vesicles in colorectal cancer.Annals of coloproctology · 2025
    Review
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Jongmin Park *Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8338-9346
Jun Seok Park *Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Chen-Han HuangCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ala JoCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kaitlyn CookDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3794-3312
Rui WangDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5007-193X
Hsing-Ying LinCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jan Van DeunCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Huiyan LiCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jouha MinCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6737-7254
Lan WangDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ghilsuk YoonDepartment of Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.
Bob S CarterDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Leonora BalajDepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0931-9715
Gyu-Seog ChoiDepartment of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea.
Cesar M CastroCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. rweissleder@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-0828-4143
Hakho LeeCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. hlee@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-0087-0909
Harvard University · USKyungpook National University · KRKyungpook National University Hospital · KR

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHIOCCA, E. ANTONIO · 1996 to 2021
$30.9M
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomasU01CA230697 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S, SKOG, JOHAN · 2018 to 2022
$4.0M
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with NanoplasmonicsU01CA233360 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CASTRO, CESAR M, DINULESCU, DANIELA M · 2018 to 2022
$3.5M
Clinical platform for high-throughput analyses of extracellular vesiclesR01CA229777 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, SKOG, JOHAN · 2018 to 2022
$3.2M
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment MonitoringR01CA239078 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BALAJ, LEONORA, LEE, HAKHO · 2020 to 2024
$3.1M
exRNA Biomarkers for Human GliomaUH3TR000931 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARTER, BOB S, HOCHBERG, FRED H · 2015 to 2017
$3.0M
Standardized Molecular Analyses of Glioma EVsR01CA237500 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S, LEE, HAKHO · 2020 to 2024
$3.0M
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLESR01HL113156 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO · 2012 to 2016
$2.1M
Multiplexed analysis of exosomes in cancer nano therapyR01CA204019 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2016 to 2020
$1.9M
Molecular subtyping of brain tumors using a blood-based multiplexed assayR01CA291826 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Leonora Balaj, Bob S Carter · 2025 to 2026
$1.3M
exRNA Biomarkers for Human GliomaUH2TR000931 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARTER, BOB S, HOCHBERG, FRED H · 2013 to 2014
$1.1M
High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposureR21DA049577 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, PENDYALA, GURUDUTT · 2019 to 2020
$458k
NCATS NIH HHS UH2 TR000931NCATS NIH HHS UH3 TR000931NCI NIH HHS P01 CA069246NCI NIH HHS R01 CA204019NCI NIH HHS R01 CA229777NCI NIH HHS R01 CA237500NCI NIH HHS R01 CA239078NCI NIH HHS R01 CA291826NCI NIH HHS R21 CA205322NCI NIH HHS U01 CA230697NCI NIH HHS U01 CA233360NHLBI NIH HHS R01 HL113156NIDA NIH HHS R21 DA049577
6 · The paper itself

Abstract

Assays for cancer diagnosis via the analysis of biomarkers on circulating extracellular vesicles (EVs) typically have lengthy sample workups, limited throughput or insufficient sensitivity, or do not use clinically validated biomarkers. Here we report the development and performance of a 96-well assay that integrates the enrichment of EVs by antibody-coated magnetic beads and the electrochemical detection, in less than one hour of total assay time, of EV-bound proteins after enzymatic amplification. By using the assay with a combination of antibodies for clinically relevant tumour biomarkers (EGFR, EpCAM, CD24 and GPA33) of colorectal cancer (CRC), we classified plasma samples from 102 patients with CRC and 40 non-CRC controls with accuracies of more than 96%, prospectively assessed a cohort of 90 patients, for whom the burden of tumour EVs was predictive of five-year disease-free survival, and longitudinally analysed plasma from 11 patients, for whom the EV burden declined after surgery and increased on relapse. Rapid assays for the detection of combinations of tumour biomarkers in plasma EVs may aid cancer detection and patient monitoring.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ImmobilizedArea Under CurveBiomarkers, TumorColorectal NeoplasmsDisease-Free SurvivalElectrochemical TechniquesEpithelial Cell Adhesion MoleculeExtracellular VesiclesFemaleHumansKaplan-Meier EstimateLongitudinal StudiesAntibodies, ImmobilizedBiomarkers, TumorEPCAM protein, humanEpithelial Cell Adhesion Molecule

Identifiers

PMID34183802
PMCPMC8437135
OpenAlexW3176014217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.